Literature DB >> 9786855

Isolation of TAO1, a protein kinase that activates MEKs in stress-activated protein kinase cascades.

M Hutchison1, K S Berman, M H Cobb.   

Abstract

Several components of the budding yeast pheromone-response pathway are conserved in mammalian mitogen-activated protein (MAP) kinase pathways. Thus, we used degenerate oligonucleotides derived from the sequence of the Saccharomyces cerevisiae protein kinase Ste20p to amplify related sequences from the rat. One of these sequences was used to clone a rat Ste20p homolog, which we called TAO1 for its one thousand and one amino acids. Northern analysis shows TAO1 is highly expressed in brain, as is a homolog TAO2. Recombinant TAO1 was expressed and purified from Sf9 cells. In vitro, it activated MAP/extracellular signal-regulated protein kinase (ERK) kinases (MEKs) 3, 4, and 6 of the stress-responsive MAP kinase pathways, but not MEK1 or 2 of the classical MAP kinase pathway. TAO1 activated MEK3 but not MEK4 or MEK6 in transfected cells. MEK3 coimmunoprecipitated with TAO1 when they were expressed in 293 cells. In addition, immunoreactive MEK3 endogenous to Sf9 cells copurified with TAO1 produced from a recombinant baculovirus. The activation of and binding to MEK3 by TAO1 implicates TAO1 in the regulation of the p38-containing stress-responsive MAP kinase pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9786855     DOI: 10.1074/jbc.273.44.28625

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Genetic modifiers of tauopathy in Drosophila.

Authors:  Joshua M Shulman; Mel B Feany
Journal:  Genetics       Date:  2003-11       Impact factor: 4.562

2.  Tao-1 is a negative regulator of microtubule plus-end growth.

Authors:  Tao Liu; Jennifer L Rohn; Remigio Picone; Patricia Kunda; Buzz Baum
Journal:  J Cell Sci       Date:  2010-07-20       Impact factor: 5.285

3.  Re-evaluating the role of Tao1 in the spindle checkpoint.

Authors:  Frederick G Westhorpe; Maria A Diez; Mark D J Gurden; Anthony Tighe; Stephen S Taylor
Journal:  Chromosoma       Date:  2010-02-17       Impact factor: 4.316

Review 4.  The ERK cascade: a prototype of MAPK signaling.

Authors:  Hadara Rubinfeld; Rony Seger
Journal:  Mol Biotechnol       Date:  2005-10       Impact factor: 2.695

5.  PAK5 kinase is an inhibitor of MARK/Par-1, which leads to stable microtubules and dynamic actin.

Authors:  Dorthe Matenia; Bettina Griesshaber; Xiao-yu Li; Anja Thiessen; Cindy Johne; Jian Jiao; Eckhard Mandelkow; Eva-Maria Mandelkow
Journal:  Mol Biol Cell       Date:  2005-07-12       Impact factor: 4.138

Review 6.  MAP kinase pathways: the first twenty years.

Authors:  Joseph Avruch
Journal:  Biochim Biophys Acta       Date:  2006-11-15

7.  De Novo Variants in TAOK1 Cause Neurodevelopmental Disorders.

Authors:  Marija Dulovic-Mahlow; Joanne Trinh; Krishna Kumar Kandaswamy; Geir Julius Braathen; Nataliya Di Donato; Elisa Rahikkala; Skadi Beblo; Martin Werber; Victor Krajka; Øyvind L Busk; Hauke Baumann; Nouriya Abbas Al-Sannaa; Frauke Hinrichs; Rabea Affan; Nir Navot; Mohammed A Al Balwi; Gabriela Oprea; Øystein L Holla; Maximilian E R Weiss; Rami A Jamra; Anne-Karin Kahlert; Shivendra Kishore; Kristian Tveten; Melissa Vos; Arndt Rolfs; Katja Lohmann
Journal:  Am J Hum Genet       Date:  2019-06-20       Impact factor: 11.025

8.  TAO kinases mediate activation of p38 in response to DNA damage.

Authors:  Malavika Raman; Svetlana Earnest; Kai Zhang; Yingming Zhao; Melanie H Cobb
Journal:  EMBO J       Date:  2007-03-29       Impact factor: 11.598

9.  TAOK1 negatively regulates IL-17-mediated signaling and inflammation.

Authors:  Zhaoru Zhang; Zhen Tang; Xianwei Ma; Kai Sun; Liping Fan; Jie Fang; Jianping Pan; Xiaojian Wang; Huazhang An; Jun Zhou
Journal:  Cell Mol Immunol       Date:  2018-02-05       Impact factor: 11.530

10.  MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK/PAR-1.

Authors:  Thomas Timm; Xiao-Yu Li; Jacek Biernat; Jian Jiao; Eckhard Mandelkow; Joel Vandekerckhove; Eva-Maria Mandelkow
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.